Judith Hasko > WilmerHale > San Francisco, United States > Lawyer Profile
WilmerHale Offices
![WilmerHale company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/51073.jpg?v=1653300455)
1 Front Street
Suite 3500
CALIFORNIA
94111
United States
- Firm Profile
- Go to...
Judith Hasko
![Judith Hasko photo](https://www.legal500.com/wp-content/uploads/sites/13/2024/06/Hasko_Judith-300x300.jpg)
Work Department
Emerging Company and Venture Capital; Life Sciences; Healthcare; Technology Transactions and Licensing
Position
Partner
Co-Chair, Life Sciences Group
Career
Judith Hasko serves as co-chair of WilmerHale’s Life Sciences Practice. She provides counsel to life sciences companies and their investors on strategic, intellectual property and technology-based commercial transactions. Companies in the biotechnology, pharmaceutical, medical device and diagnostic product sectors, along with their investors, depend on Ms. Hasko for guidance and execution of licensing, corporate partnerships, joint ventures, co-promotion arrangements, manufacturing and distribution agreements, asset purchases and royalty stream transactions.
Widely recognized for her market-leading transactional work, Ms. Hasko brings complementary business and scientific perspectives to her legal representations. Her work in the life sciences industry is consistently recognized by Chambers USA, The Legal 500 United States, IAM Patent and LMG Life Sciences. Ms. Hasko is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Prior to attending law school, she was part of Genentech’s cardiovascular research department.
Prior to joining the firm, Ms. Hasko was a partner in the Silicon Valley office of another major international law firm, where served as vice chair of their Healthcare & Life Sciences Practice.
Professional Activities
Ms. Hasko has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University.
Memberships
Bar Admissions:
California
US Patent and Trademark Office
Education
JD, University of Wisconsin Law School, 1994
MPhil, University of Sussex, 1988
BA, Vassar College, 1986
Lawyer Rankings
United States > Healthcare > Life sciences
(Leading lawyers)Pharmaceutical companies, academic institutions and investors come to WilmerHale for advice on critical transactions, including M&A, joint ventures and strategic alliances, in addition to being entrusted with complex patent disputes. Stuart Falber is sought after by a range of established players and new market entrants, including VC investors, for IPOs, spinoffs and licensing deals, leading the team alongside Lisa Pirozzolo, who represents clients in patent infringement and contractual litigation; both are based in Boston. In Washington DC, Amy Wigmore brings further litigious experience, handling a range of matters under the Hatch-Waxman Act and concerning biosimilars. Judith Hasko joined in Palo from Latham & Watkins LLP in June 2024, bringing significant experience.
United States > Intellectual property > Patents: licensing
(Leading lawyers)Lawyer Rankings
- Leading lawyers United States > Intellectual property > Patents: licensing
- Leading lawyers United States > Healthcare > Life sciences
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Finance > Financial services regulation
- Antitrust > Cartel
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Industry focus > Education
- Industry focus > Education
- Intellectual property > Patents: licensing
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Government > State attorneys general
- Media, technology and telecoms > Technology transactions
- International trade > Trade remedies and trade policy
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: equity offerings
- M&A/corporate and commercial > Corporate governance
- International trade > Customs, export controls and economic sanctions
- Government > Government contracts
- Government > Government relations
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (International Trade Commission)
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense